Tonia Becker, Life Sciences Editor, Macon Raine talks with BioTechLogic’s Ted Condez How is the medical device and biopharmaceutical...
Read moreArticles
Lessons and Insights into the Korean Biopharmaceutical Market During the COVID-19 Pandemic
Tonia Becker, Life Sciences Editor, Macon Raine talks with BioTechLogic’s Dr. Eileen Choi How is the COVID-19 pandemic affecting the global biopharmaceutical market?...
Biopharmaceutical Developers Tackle COVID-19 Pandemic-Inflicted Challenges
Tonia Becker, Life Sciences Editor, Macon Raine, talks with BioTechLogic’s Dr. Mike Berry. Knowing that BioTechLogic’s team of biopharmaceutical consultants is working...
Contact Surface and Hand Disinfection – Applying Pharma’s Disinfectant Efficacy Concepts for COVID-19
By Tracy TreDenick-Fricke, BioTechLogic, Head of Regulatory and Quality, and Senior Consultant Most of us now understand that SARS-CoV-2 (the cause of COVID-19) is often transmitted via respiratory droplets. However, SARS-CoV-2 is also spread by contaminated contact surfaces and hands, but all contact surfaces are not created equally. A chart published by the Journal of Hospital Infection is quite helpful for understanding the persistence of the virus on various surfaces.
The Evolution of Therapeutic Monoclonal Antibodies
By Tracy TreDenick, Head of Regulatory and Quality, and Senior Consultant, BioTechLogic The elegant simplicity of monoclonal antibodies (mAbs) has catapulted them to a...
FDA Seeking to Enhance Manufacturing of Cell Therapy and Gene Therapy Products
More consistent and reliable production cell therapy and gene therapy processes are critical for advancing innovative treatments. While cell therapy and gene therapy...
Recent Posts
- Top 25 Biotech Companies of 2024
- The EU Clinical Trials Regulation – Experiences from the First 18 Months
- CMC Expertise Accelerating Biologics Development for 20 Years and Counting
- Strengthening Your Gene Therapy Process Control Strategy
- Designing a Gene Therapy CMC Architecture for the Full Product Lifecycle